EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H29NO |
| Net Charge | 0 |
| Average Mass | 311.469 |
| Monoisotopic Mass | 311.22491 |
| SMILES | OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2 |
| InChI | InChI=1S/C21H29NO/c23-21(19-7-3-1-4-8-19,11-14-22-12-5-2-6-13-22)20-16-17-9-10-18(20)15-17/h1,3-4,7-10,17-18,20,23H,2,5-6,11-16H2 |
| InChIKey | YSXKPIUOCJLQIE-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Biological Roles: | parasympatholytic Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists. muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. |
| Applications: | antidyskinesia agent Any compound which can be used to treat or alleviate the symptoms of dyskinesia. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. antidote to sarin poisoning A role borne by a molecule that acts to counteract or neutralise the nerve agent sarin. parasympatholytic Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists. antiparkinson drug A drug used in the treatment of Parkinson's disease. muscarinic antagonist A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| biperiden (CHEBI:3112) has role antidepressant (CHEBI:35469) |
| biperiden (CHEBI:3112) has role antidote to sarin poisoning (CHEBI:136860) |
| biperiden (CHEBI:3112) has role antidyskinesia agent (CHEBI:66956) |
| biperiden (CHEBI:3112) has role antiparkinson drug (CHEBI:48407) |
| biperiden (CHEBI:3112) has role antipsychotic agent (CHEBI:35476) |
| biperiden (CHEBI:3112) has role anxiolytic drug (CHEBI:35474) |
| biperiden (CHEBI:3112) has role muscarinic antagonist (CHEBI:48876) |
| biperiden (CHEBI:3112) has role parasympatholytic (CHEBI:50370) |
| biperiden (CHEBI:3112) is a piperidines (CHEBI:26151) |
| biperiden (CHEBI:3112) is a tertiary alcohol (CHEBI:26878) |
| biperiden (CHEBI:3112) is a tertiary amino compound (CHEBI:50996) |
| Incoming Relation(s) |
| biperiden hydrochloride (CHEBI:59171) has part biperiden (CHEBI:3112) |
| IUPAC Name |
|---|
| 1-(bicyclo[2.2.1]hept-5-en-2-yl)-1-phenyl-3-(piperidin-1-yl)propan-1-ol |
| INNs | Source |
|---|---|
| biperiden | ChemIDplus |
| biperidene | ChemIDplus |
| biperideno | ChemIDplus |
| biperidenum | ChemIDplus |
| Synonyms | Source |
|---|---|
| 1-Bicyclo[2.2.1]hept-5-en-2-yl-1-phenyl-3-piperidin-1-yl-propan-1-ol | ChEMBL |
| Akineton- | ChEMBL |
| KL 373 | ChEMBL |
| NSC-759145 | ChEMBL |
| α-5-norbornen-2-yl-α-phenyl-1-piperidinepropanol | ChEBI |
| α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-1-piperidinepropanol | ChEBI |
| Citations |
|---|